Pediatric HIV AIDS
More than 90% of HIV infections in children are due to mother-to-child transmission, which occurs when an HIV-positive mother passes the virus to her child during the perinatal period, during childbirth or breastfeeding. The likelihood of this type of transmission increases directly with the severity of the mother's HIV contamination.
Offspring living with HIV are exterminated more ruthlessly than adults because their immune systems are not fully formed. They may be exposed to the same common pediatric contamination as HIV-negative youngsters, but they will not be able to combat them as viable. Ear and sinus infections, sepsis, pneumonia, TB, urinary tract disease, duodenal disease, skin disease and meningitis are all common infections among HIV-positive young people. Tuberculosis, runs and respiratory diseases are common among HIV-positive children in the formation of nations.
Related Conference of Pediatric HIV AIDS
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
Pediatric HIV AIDS Conference Speakers
Recommended Sessions
- HIV Drug Discovery and Research
- AIDS stigma and discrimination
- Awareness and knowledge on HIV/AIDS, STDs and STIs
- Emerging Technologies towards HIV/AIDS
- HIV & Vaccines
- HIV and Aging
- HIV and AIDS Nursing Care Management
- HIV and bone damage
- HIV and cardiovascular disease
- HIV and Retroviral Diseases
- HIV Diagnosis and Therapy
- HIV in women
- HIV Testing
- HIV/AIDS Nursing and AIDS awareness
- Lived experience of HIV
- Pediatric HIV AIDS
- Side effects of HIV
- Venereal Diseases Prevention and Treatment
- Viral Immunology and Vaccines development
- Viral, Bacterial, Fungal & Protozoan STDs
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)